Elevation OncologyELEV
13F holders, Q3 2025 (September 30)1holders −64
0new positions
64sold out
$0.36avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Elevation Oncology Inc. (ELEV) in their 13F filings, down 64 from Q2 2025. 0 opened new positions and 64 sold out. The largest holder was Osaic Holdings, Inc. ($720).
- Company
- Elevation Oncology Inc.
- CUSIP
- 28623U101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 64 | $10.8M |
All 13F filers, Q2 2025 → Q3 2025: 29,539,190 shares sold, net −29,539,190 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Osaic Holdings, Inc. | 0.00% | No change | 2,000 | $720 |
"% of holder's portfolio" is ELEV's weight in each manager's 13F, not the share of Elevation Oncology Inc. the manager owns.